DrugPatentWatch Database Preview
Drugs in Development Information for Huperzine-A
Email this page to a colleague
What is the drug development status for Huperzine-A?
Huperzine-A is an investigational drug.
There have been 11 clinical trials for Huperzine-A.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Alzheimer Disease, Cognition Disorders, and Schizophrenia. The leading clinical trial sponsors are Shandong Luye Pharmaceutical Co., Ltd., Alzheimer's Disease Cooperative Study (ADCS), and VA Nebraska Western Iowa Health Care System.
Summary for Huperzine-A
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-12-01) |
| Vendors | 29 |
Recent Clinical Trials for Huperzine-A
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage | Jiangsu Famous Medical Technology Co., Ltd. | Phase 4 |
| Effects of Hearing Rehabilitative Interventions and Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD) | Zhijun Bao | N/A |
| Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging | Shanghai Mental Health Center | Phase 4 |
Clinical Trial Summary for Huperzine-A
Top disease conditions for Huperzine-A
Top clinical trial sponsors for Huperzine-A
US Patents for Huperzine-A
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
